• 18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report
• A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery?
• A Perspective Review: Analyzing Collagen Alterations in Ovarian Cancer by High-Resolution Optical Microscopy
• A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)
• A Review: Biomechanical Aspects of the Fallopian Tube Relevant to its Function in Fertility
• An Incidental Fallopian Tube Focal Serous Tubal Intraepithelial Lesion (STIL) Discovered on a Postoperative Pathology Report Following Hysterectomy and Salpingectomy: A Case Report
• An international worldwide retrospective cohort observational study comparing primary cytoreductive surgery with neoadjuvant chemotherapy and interval cytoreductive surgery in patients with carcinoma of the ovary, fallopian tubes, and peritoneum (SUROVA t
• Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma
• ARIA II: a randomized controlled trial of near-infrared Angiography during RectosIgmoid resection and Anastomosis in women with ovarian cancer
• Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
• Bowel perforation with generalised peritonitis secondary to recurrent primary fallopian tube carcinoma after 17 years
• British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024
• Cancer incidence, stage shift and survival during the 2020 COVID-19 pandemic: A population-based study in Belgium
• Cardiovascular adverse events associated with PARP inhibitors for ovarian cancer: a real world study (RWS) with Bayesian disproportional analysis based on the FDA adverse event reporting system (FAERS)
• Case report: diagnosis and treatment of advanced high-grade serous ovarian carcinoma aided by ⁶⁸Ga-FAPI PET/MR scan
• Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
• Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
• Complicated pancreatic fistula after gynecologic surgery for left fallopian tube carcinosarcoma: A case report
• Comprehensive next-generation sequencing identifies novel putative pathogenic or likely pathogenic germline variants in patients with concurrent tubo-ovarian and endometrial serous and endometrioid carcinomas or precursors
• Correction: Randomised phase II trial of weekly ixabepilone biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
• Crucial computed tomography and magnetic resonance imaging findings of fallopian tubal tuberculosis for diagnosis: a retrospective study of 26 cases
• Cutting-edge Treatment for Gynecological Malignancies
• Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico
• Diagnosis Shift in Site of Origin of Tubo-Ovarian Carcinoma
• Do we more often opt for conservative management of ovarian tumors after changing the Dutch national guideline on enlarged ovaries? A nationwide cohort study
• Does serous tubal intraepithelial carcinoma (STIC) metastasize? The clonal relationship between STIC and subsequent high-grade serous carcinoma in BRCA1/2 mutation carriers several years after risk-reducing salpingo-oophorectomy
• Ectopic adrenal tissue in the mesosalpinx of an older female: the fourth case report in the literature
• Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study
• Endometrioid carcinoma of the fallopian tube misdiagnosed as an infected endometrioma: A case report
• Examining the impact of age on chemotherapy completion in epithelial ovarian, fallopian tube and primary peritoneal cancer: a retrospective cohort study in Thailand
• Fallopian tube single cell analysis reveals myeloid cell alterations in high-grade serous ovarian cancer
• Fallopian Tube-Derived High-Grade Serous Cancers Influence Ovarian Production of Norepinephrine and Generate Specific Metabolomic Signatures
• Feasibility of articulating laparoscopic instrument use in laparoscopic adnexectomy: a multicenter prospective observational study
• Female Adnexal Tumor of Probable Wolffian Origin (Wolffian Tumor): A Potential Mimic of Peritoneal Mesothelioma
• First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial
• Follicular fluid aids cell adhesion, spreading in an age independent manner and shows an age-dependent effect on DNA damage in fallopian tube epithelial cells
• Gastric-type glandular lesions of the female genital tract excluding the cervix: emerging pathological entities
• Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing
• Genomic Catastrophe (Chromothripsis and Polyploidy) Correlates With Tumor Distribution in Extrauterine High-grade Serous Carcinoma
• Giving birth after fertility-sparing treatment for primary leiomyosarcoma of the fallopian tube
• Global epidemiology of epithelial ovarian cancer
• Has time to chemotherapy from primary debulking surgery in advanced ovarian cancer an impact on survival? - A population-based nationwide SweGCG study
• Hereditary Cancer Screening and Outcomes at an Urban Safety-Net Hospital
• High-grade serous carcinoma of the fallopian tube in a young woman with chromosomal 4q abnormality: A case report
• High-grade serous carcinoma of unknown primary origin associated with STIC clinically presented as isolated inguinal lymphadenopathy: a case report
• High-grade serous ovarian cancer (HGSOC) with fallopian tube involvement
• Histopathology of peritonitis due to infectious mononucleosis with background Chlamydia trachomatis infection: A case report and literature review
• Human peritoneal fluid exerts ovulation- and nonovulation-sourced oncogenic activities on transforming fallopian tube epithelial cells
• Identification of fallopian tube microbiota and its association with ovarian cancer
• Identification of long noncoding RNAs downregulated specifically in ovarian high-grade serous carcinoma
• Immunohistochemical and molecular pattern of p53 in epithelial ovarian cancers negative for germline BRCA1/2 variants
• Incidental Hemangioma in Tubectomy and Hemorrhoidectomy Specimens: A Report of Two Cases
• Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin
• Intraoperative Ketorolac and Outcomes after Ovarian Cancer Surgery
• ISGylation enhances double-stranded RNA-induced interferon response and NFkappaB signaling in fallopian tube epithelial cells
• Locus-specific LINE-1 expression in clinical ovarian cancer specimens at the single-cell level
• Metastasis of colorectal cancer to the uterine body and fallopian tube: case report and literature review
• MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer
• Misdiagnosis of a Drain-site Hernia Containing Fallopian Tube Fimbria on (18)F-FDG PET/CT
• Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection
• Natural Killer Cell Dysfunction in Premenopausal <em>BRCA1</em> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
• NB compounds are potent and efficacious FOXM1 inhibitors in high-grade serous ovarian cancer cells
• Niraparib for the treatment of metastatic ccRCC in a patient with <em>CDK12</em> and <em>RAD51C</em> mutations: a case report
• Niraparib maintenance therapy using an individualised starting dose in patients with platinum-sensitive recurrent ovarian cancer (NORA): final overall survival analysis of a phase 3 randomised, placebo-controlled trial
• No Racial Disparities Observed Using Point-of-Care Genetic Counseling and Testing for Endometrial and Ovarian Cancer in a Diverse Patient Population: A Retrospective Cohort Study
• Olaparib maintenance therapy for platinum-sensitive relapsed ovarian cancer at a single institution: A retrospective study
• Ovarian Cancer in the Older Manitoban Population-Treatment Tolerance and Cancer-Related Outcomes: A Manitoba Ovarian Cancer Outcomes (MOCO) Group Study
• Pembrolizumab with bevacizumab and cyclophosphamide for the treatment of recurrent ovarian clear cell carcinoma: A case series
• Peritoneal Recurrence of Squamous Cell Carcinoma in a Young Woman After Conization for Microinvasive Cervical Cancer
• Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (FRalpha)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer
• Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study
• Predictors of olaparib discontinuation owing to adverse drug events in patients with ovarian, peritoneal, or fallopian tube cancer: a retrospective observational study
• Prevalence and spectrum of germline BRCA1 and BRCA2 in a cohort of ovarian cancer patients from the Salento peninsula (Southern Italy): a matter of preventive health
• Primary fallopian tube carcinoma diagnosed 29 years after bilateral partial salpingectomy: A case report
• Primary fallopian tube endometroid carcinoma: A rare case report
• Primary mucinous gland lesions of fallopian tube: a clinicopathological analysis of fourteen cases
• Primary ovarian cancer combined with primary fallopian tube cancer: A case report
• Proteomic analysis of ascitic extracellular vesicles describes tumour microenvironment and predicts patient survival in ovarian cancer
• Pseudocarcinomatous hyperplasia of the fallopian tube: a clinicopathological analysis of sixteen cases
• Rates of paclitaxel hypersensitivity reactions using a modified Markman's infusion protocol as primary prophylaxis
• Risk-reducing salpingectomy with delayed oophorectomy to prevent ovarian cancer in women with an increased inherited risk: insights into an alternative strategy
• Robotic HIPEC with use of a vaginal GelPoint®
• Salpingectomy for ectopic pregnancy reduces ovarian cancer risk-a nation-wide study
• Salpingectomy for ovarian cancer prevention: Video education for the surgeon
• Small-cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview
• Stromal mediated DNA damage promotes high grade serous ovarian cancer initiation
• Suvemcitug plus chemotherapy for platinum-resistant epithelial ovarian, fallopian tube and primary peritoneal cancer: A phase 1b dose-escalation trial
• Synchronous profiling of mRNA N6-methyladenosine modifications and mRNA expression in high-grade serous ovarian cancer: a pilot study
• Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression
• The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer
• The G-Protein-Coupled Estrogen Receptor Selective Agonist G-1 Attenuates Cell Viability and Migration in High-Grade Serous Ovarian Cancer Cell Lines
• The genomic trajectory of ovarian high-grade serous carcinoma can be observed in STIC lesions
• The Impact of Opportunistic Salpingectomy on Ovarian Reserve: A Systematic Review
• The impact of Paclitaxel-based hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer patients - interim analysis of safety and immediate efficacy of a randomized control trial (C-HOC trial)
• The Incidental Diagnosis of Adenomatoid Tumour on Fallopian Tubes Submitted for Tubal Ligation at a Tertiary Laboratory in Northern Pretoria, South Africa
• The karyometric signature is altered in fallopian tubes with serous tubal intraepithelial carcinoma
• The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancer
• Therapeutic roles of platelet-rich plasma to restore female reproductive and endocrine dysfunction
• VHL-mutated papillary cystadenoma of the mesosalpinx with omental tumor deposits and immunophenotypic overlap with mesothelioma
• Xanthomatous salpingo-oophoritis accompanied by hobnail cell and apocrine metaplasia: The first case report in the literature